OSI PHARMACEUTICALS, INC. AMENDED AND RESTATED STOCK INCENTIVE PLAN DEFERRED STOCK UNIT AGREEMENTDeferred Stock Unit Agreement • August 7th, 2007 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
THIS DEFERRED STOCK UNIT AGREEMENT (the “Agreement”) is made as of , 200___, by and between OSI PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [DIRECTOR] (the “Director”). Capitalized terms, unless otherwise defined herein, shall have their respective meanings as set forth in the OSI Pharmaceuticals, Inc. Amended and Restated Stock Incentive Plan, as amended (the “Plan”).
CONSULTING AGREEMENTConsulting Agreement • August 7th, 2007 • Osi Pharmaceuticals Inc • In vitro & in vivo diagnostic substances • New York
This Consulting Agreement (“Agreement”) is signed on April 28, 2006 and effective as of May 2, 2006 (“Effective Date”) by and between OSI Pharmaceuticals, Inc., a Delaware corporation (together with its affiliates and subsidiaries, “OSI”), having executive offices at 41 Pinelawn Road, Melville, New York 11747, and David Guyer (“Consultant”), having an address at **.
